---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-395511"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2026-09-18T20:05:16+00:00"
generated_at: "2026-09-18T20:06:22.078593+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics closes $0.5M private placement with CSO; shareholders approve warrant issuance

## Summary
- CSO Hamid Khoja purchased 298,508 shares plus warrants at $1.675 combined price ($1.55 stock + $0.125 warrant) on Sept 15, 2026.
- Gross proceeds ~$0.5M; net proceeds to be used for general corporate purposes and working capital.
- Warrants exercisable at $1.55, immediately exercisable, expire in 5 years from issuance.
- Shareholders approved issuance of up to 8,448,980 shares (8,163,266 + 285,714) upon warrant exercise; votes: 3,153,098 for, 258,217 against.
- Special meeting held Sept 17, 2026; 3,431,761 shares represented out of 8,283,193 entitled to vote.

## SEC filing metadata
- accession: 0001193125-26-395511
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2026-09-18T20:05:16+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000119312526395511/0001193125-26-395511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526395511/fblg-20260917.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-395511
- JSON: https://secwatch.observer/filing/0001193125-26-395511.json
- Plain text: https://secwatch.observer/filing/0001193125-26-395511.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.